Cargando…
Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.
SR2508 sensitises certain hypoxic tumor cells in vitro and in vivo to the cytotoxic action of radiation and alkylating agents. The mechanism of sensitisation may derive in part from depletion of glutathione (GSH) and possibly inhibition of GSH-dependent enzymes in target cells. We treated 46 evaluab...
Autores principales: | O'Dwyer, P. J., LaCreta, F. P., Walczak, J., Cox, T., Litwin, S., Hoffman, J. P., Zimny, M., Comis, R. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968592/ https://www.ncbi.nlm.nih.gov/pubmed/8398704 |
Ejemplares similares
-
Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
por: Tetorou, Konstantina, et al.
Publicado: (2021) -
Major Membrane Protein TDE2508 Regulates Adhesive Potency in Treponema denticola
por: Abiko, Yuki, et al.
Publicado: (2014) -
2508: The role of platelet factor-4 (PF4 or CXCL4) in B cell differentiation
por: Blick, Sara, et al.
Publicado: (2018) -
TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt
por: Szegezdi, E, et al.
Publicado: (2006) -
2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
por: Srivastava, Pronoma, et al.
Publicado: (2023)